Project key to testing the effectiveness of potential treatments

Soldiers who suffer internal trauma from explosions might one day benefit from a new treatment now under development.

A newly developed spectroscopy method is helping to clarify the poorly understood molecular process by which an anti-HIV drug induces lethal mutations in the virus’ genetic material. The findings from the University of Chicago and the Massachusetts Institute of Technology could bolster efforts to develop the next generation of anti-viral treatments.

Research from the University of Manchester using cutting edge computer analysis reveals that despite mutating, Ebola hasn’t evolved to become deadlier since the first outbreak 40 years ago.

Manufacturers should include this information on labels, say researchers

A growing body of evidence in the medical community holds that greater diversity of bacteria and even worms in the digestive tract offers protection against a variety of allergic and autoimmune problems.

Consumers are one step closer to benefiting from packaging that could give simple text warnings when food is contaminated with deadly pathogens like E. coli and Salmonella, and patients could soon receive real-time diagnoses of infections such as C. difficile right in their doctors’ offices, saving critical time and trips to the lab.

An Ebola whole virus vaccine, constructed using a novel experimental platform, has been shown to effectively protect monkeys exposed to the often fatal virus.

A new study by scientists at the Wayne State University School of Medicine sheds significant light on our understanding of how brain networks contribute to obsessive-compulsive disorder in youth. Led by David Rosenberg, M.D., and Vaibhav Diwadkar, Ph.D., of the Department of Psychiatry and Behavioral Neurosciences, the research demonstrates that communication between some of the brain’s most important centers is altered in the disorder.

Study at Berkeley Lab’s Advanced Light Source shows why skin is resistant to tearing.

Neurodegenerative diseases, such as Alzheimer's and Parkinson's, affect more than 6.4 million Americans, according to the Harvard NeuroDiscovery Center. That number may double in the next 30 years as the population ages, unless medical researchers figure out what's happening at a cellular and molecular level and develop ways to treat or prevent these debilitating conditions.